Daftar Pustaka 1. World Cancer Report 2014. WHO Report 2014

Daftar Pustaka
1. World
Cancer
Report
2014.
WHO
Report
2014.Dikutip
dari
http://www.who.int/mediacentre/factsheets/fs297/en/
2. Sofian A. Kanker Endometrium. In Aziz MF, A, Saifuddin AB, editors.
Onkologi Ginekologi : Buku Acuan Nasional. Jakarta: Yayasan Bina Pustaka
Sarwono Prawirohardjo; 2006. p. 456-467.
3. American Cancer Society. Cancer Facts and Figures 2008.2008.Dikutip dari
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259524/
4. Ries L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 19752005.2008. Dikutip dari http://seer.cancer.gov/csr/1975_2005/
5. Merill RM. Impact of hysterectomy and bilateral oophorectomy on racespecific rates of corpus, cervical, and ovarian cancers in the United States. Ann
Epidemiol.2006;16(12):880-7.
6. Cramer DW. The Epidemiology of Endometrial and Ovarian Cancer.2011.
7. Mills AM, Longacre TA. Endometrial hyperplasia. Semin Diagn Pathol
2010;27:199-214.
8. Kitchener HC. Chapter 57: cancer of the uterine corpus. In: Edmonds DK, ed.
Dewhurst’s textbook of obstetric and gynaecology. 7th ed. Blackwell
Publishing, 2007.
9. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I.
Endometrial cancer. Lancet2005;366:491-505.
10. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL,
et al. Carcinoma of the corpus uteri. FIGO 6th annual report on the results of
treatment in gynecological cancer. Int J Gynaecol Obstet 2006;95:S105-43.
11. Parazzini F, LaVecchia C, Bocciolone L, Franceschi S. The epidemiology of
endometrial cancer. Gynecology Oncology 1991;41:1-16.
12. Jemal A, Siegel R, Murray T, Hao Y, Xu J, Murray T, et al. Cancer statistics,
2009. CA Cancer J Clin 2009.
13. Madison T, Schottenfeld D, Baker V. Cancer of the corpus uteri in white and
black women in Michigan, 1985-1994. Cancer 1998;83:1546-1554.
30
Universitas Sumatra Utara
31
14. Creasman WT. Endometrial cancer: incidence, prognostic factors, diagnosis,
and treatment. Semin Oncol. 1997 Feb. 24(1 Suppl 1):S1-140-S1-50.
15. Bernstein L, Deapen D, Cerhan JR, et al. Tamoxifen therapy for breast cancer
and endometrial cancer risk.J Natl Cancer Inst. 1999 Oct 6. 91(19):1654-62.
16. Berek, Hacker. Uterine cancer. Berek and Hacker's Gynecologic Oncology, 5th
Edition, 2010.p. 397-401
17. Kurman RJ, et al WHO Classification of tumours of female reproductive organs
Edisi 4, 2014.p. 122-133
18. Kaku T, Kimura T, Kirakawa T, et al. Endometrial carcinoma associated with
hyperplasia : immunohistochemical study of angiogenesis and p53 expression.
Gynecol Oncol 1999; 72:51-5
19. Cirisiano FD, Robboy SJ, Dodge RK, et al. The outcome of stage I-II clinically
and surgically staged papillary serous and clear cell endometrial cancers when
compared with endometrioid carcinoma. Gynecol Oncol 2000; 77: 243-8
20. Nucci MR dan Oliva E. Endometrial Neoplasia. Gynecologic Pathology,
2009.p. 233-58
21. Shepherd, J.H. dan Monaghan, J.M. Carcinoma of the uterine body. Clinical
Gynaecological Oncology, 1985.
22. Silverberg S.G. & De Giorgi L.S. (1973) Clear cell carcinoma of the
endometrium: clinical, pathologic and ultrastructural findings. Cancer,
31,1127.
23. Connelly PJ, Alberhashy RC & Christopherson WM. Carcinoma of the
endometrium III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma. Obstet. Gynecol.1982.p. 59,569.
24. Christopherson W.M., Alberhasky R.C & Connelly P.J. (1982) Carcinoma of
the endometrium: I. A clinic-pathological study of clear-cell carcinoma and
secretory carcinoma. Cancer, 49(8).p.1511.
25. International Federation of Gynecology and Obstetrics. Cancer of the Corpus
Uteri. In F. Amant, editor. FIGO Cancer Report 2015 : Elsevier, 2015. P. S96S102.
Universitas Sumatra Utara
32
26. Baker TR. Endometrial Carcinoma. In Handbook of Gynecologic Oncology 2nd
ed. Little Brown and Company, USA, 1996.p. 141-56
27. Sofian A, Kamposo N, Siregar B. Aspek klinikopatologi penderita kanker
Endometrium di RSUP NCM tahun 1994-2003 dan peran pemeriksaan
Immunohistokimia
Vimentin
sebagai
penanda
asal
jaringan
kanker
endometrium, Subbagian Onkologi – Ginekologi FK-UI/RSCM, 2005.
28. Zaino RJ. The fruits of our Labors : Distinguishing Endometrial from
Endocervical Adenocarcinoma, Int J Gynecol Pathol 2002; 21 (1): 1-3
29. Gershenson DM et al. Cancer of the uterine corpus. In Gynecologic cancer
controversies in management, Elsevier; 2004.p. 187-217
30. Peters AAW, Trimbos JB, Nagel HTC. Onco Guide. Organon BV-The
Netherlands;2000.p. 19-23
31. Tulumang AJ, Loho FM, Mamengko ML. Gambaran kanker endometrium
yang dirawat di RSUP Prof. Dr. R.D. Kandou Manado periode 2013-2015;
2016.
32. Effendi A, Fidiawati AW, Rustam PR. Profil Penderita Karsinoma
Endometrium di RSUD Arifin Achmad PekanBaru periode 2008-2013; 2013.
33. Colombo N, Preti E, Landoni F, et al. ESMO Clinical Practice Guidelines for
diagnosis, treatment and follow up, 2011.
34. Rosato V, Zucchetto A, Bosetti C, et al. Metabolic syndrome and endometrial
cancer risk, Annals of Oncology Advance Access, 2010.
35. Schmandt ER, Iglesias AD, Co NN, et al. Understanding Obesity and
Endometrial Cancer Risk : Opportunities For Prevention, Am J Obstet Gynecol,
2011.
36. Vucenik I dan Stains PJ. Obesity and cancer risk: evidence, mechanisms and
recommendations, Annals of the New York Academy of Sciences, 2012.
Universitas Sumatra Utara